Artículos de revistas
Salivary Bpifa1 (splunc1) And Bpifa2 (splunc2 A) Are Modified By Head And Neck Cancer Radiotherapy
Registro en:
Oral Surgery, Oral Medicine, Oral Pathology And Oral Radiology. Mosby Inc., v. 119, n. 1, p. 48 - 58, 2015.
22124403
10.1016/j.oooo.2014.09.026
2-s2.0-84915818894
Autor
Gonzalez-Arriagada W.A.
Ramos L.M.A.
Silva A.A.
Vargas P.A.
Coletta R.D.
Bingle L.
Lopes M.A.
Institución
Resumen
Materials and Methods Unstimulated whole-mouth saliva was collected from 45 cancer patients (1 week before treatment, during the treatment, and 1 week after completion of radiotherapy) and from 20 controls. BPIFA1 and BPIFA2 expression was detected by western blotting and analyzed along with clinicopathologic data and side effects from the radiotherapy.Results A facial radiation field was associated with lower salivary flow during and after radiotherapy and correlated with side effects, mainly mucositis. Salivary BPIFA1 expression levels were similar between the control group and the patient group before treatment. On the other hand, BPIFA2 levels were higher in the patient group before treatment compared with the control group. BPIFA concentration was modified by radiotherapy as BPIFA1 levels increased (P =.0081) and BPIFA2 decreased (P <.0001). Higher levels of BPIFA1 were associated with the presence of mucositis (P =.0363) and its severity (P =.0500).Conclusions The present study found that levels of BPIFA1 and glycosylated forms of BPIFA2 are affected by radiotherapy, suggesting that these proteins may play a role in the oral microenvironment in irradiated patients with head and neck cancer.Objective To determine the effects of radiotherapy on salivary BPIFA expression and to investigate the role of BPIFA in the development of known radiotherapy side effects. 119 1 48 58 Siegel, R., Ma, J., Zou, Z., Jemal, A., Cancer statistics, 2014 (2014) CA Cancer J Clin, 64, pp. 9-29 Bhide, S.A., Newbold, K.L., Harrington, K.J., Nutting, C.M., Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers (2012) Br J Radiol, 85, pp. 487-494 Bourhis, J., Etessami, A., Lusinchi, A., New trends in radiotherapy for head and neck cancer (2005) Ann Oncol, 16, pp. 255-ii257 Specht, L., Oral complications in the head and neck radiation patient. Introduction and scope of the problem (2002) Support Care Cancer, 10, pp. 36-39 Vissink, A., Jansma, J., Spijkervet, F.K., Burlage, F.R., Coppes, R.P., Oral sequelae of head and neck radiotherapy (2003) CritRev Oral Biol Med, 14, pp. 199-212 Sciubba, J.J., Goldenberg, D., Oral complications of radiotherapy (2006) Lancet Oncol, 7, pp. 175-183 González Arriagada, W.A., Santos-Silva, A.R., Carvalho De Andrade, M.A., Elias, R.A., Lopes, M.A., Pre-radiotherapy dental evaluation criteria and treatment needs of oral side effects after head and neck radiotherapy (in Spanish) (2010) Int J Odontostomatol, 4, pp. 255-266 Ohrn, K.E., Sjoden, P.O., Wahlin, Y.B., Elf, M., Oral health and quality of life among patients with head and neck cancer or haematological malignancies (2001) Support Care Cancer, 9, pp. 528-538 Jham, B.C., Reis, P.M., Miranda, E.L., Oral health status of 207 head and neck cancer patients before, during and after radiotherapy (2008) Clin Oral Invest, 12, pp. 19-24 Vuotila, T., Ylikontiola, L., Sorsa, T., The relationship between MMPs and pH in whole saliva of radiated head and neck cancer patients (2002) J Oral Pathol Med, 31, pp. 329-338 Grotz, K.A., Genitsariotis, S., Vehling, D., Al-Nawas, B., Long-term oral Candida colonization, mucositis and salivary function after head and neck radiotherapy (2003) Support Care Cancer, 11, pp. 717-721 Weston, W.M., Leclair, E.E., Trzyna, W., Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung (1999) J Biol Chem, 274, pp. 13698-13703 Bingle, C.D., Bingle, L., Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern (2000) Biochimica et Biophysica Acta, 1493, pp. 36336-36337 Bingle, L., Barnes, F.A., Lunn, H., Characterisation and expression of SPLUNC2, the human orthologue of rodent parotid secretory protein (2009) Histochem Cell Biol, 132, pp. 339-349 Bingle, C.D., Gorr, S.U., Host defense in oral and airway epithelia: Chromosome 20 contributes a new protein family (2004) Int J Biochem Cell Biol, 36, pp. 2144-2152 Bingle, C.D., Craven, C.J., PLUNC: A novel family of candidate host defence proteins expressed in the upper airways and nasopharynx (2002) Hum Mol Genet, 11, pp. 937-943 Bingle, C.D., Craven, C.J., Meet the relatives: A family of BPI- and LBP-related proteins (2004) Trends Immunol, 25, pp. 53-55 Bingle, L., Bingle, C.D., Distribution of human PLUNC/BPI fold-containing (BPIF) proteins (2011) Biochem Soc Trans, 39, pp. 1023-1027 Bingle, C.D., Seal, R.L., Craven, C.J., Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI fold-containing superfamily (2011) Biochem Soc Trans, 39, pp. 977-983 Kohlgraf, K.G., Ackermann, A.R., Burnell, K.K., Quantitation of SPLUNC1 in saliva with an xMAP particle-based antibody capture and detection immunoassay (2012) Arch Oral Biol, 57, pp. 197-204 Vitorino, R., Lobo, M.J., Ferrer-Correira, A.J., Identification of human whole saliva protein components using proteomics (2004) Proteomics, 4, pp. 1109-1115 Da Silva, A.A., Bingle, L., Speight, P.M., PLUNC protein expression in major salivary glands of HIV-infected patients (2011) Oral Dis, 17, pp. 258-264 Vargas, P.A., Speight, P.M., Bingle, C.D., Barrett, A.W., Bingle, L., Expression of PLUNC family members in benign and malignant salivary gland tumours (2008) Oral Dis, 14, pp. 613-619 Gonzalez-Arriagada, W.A., Santos-Silva, A.R., Ito, F.A., Expression pattern of PLUNC proteins as an auxiliary tool for the diagnosis of high-grade mucoepidermoid carcinoma of the salivary gland (2012) J Oral Pathol Med, 41, pp. 589-597 Bingle, L., Cross, S.S., High, A.S., SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype (2005) J Pathol, 205, pp. 491-497 Cheng, M., Chen, Y., Yu, X., Tian, Z., Wei, H., Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer (2008) BMC Cancer, 8, p. 156 Iwao, K., Watanabe, T., Fujiwara, Y., Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer (2001) Int J Cancer, 91, pp. 433-437 He, Y., Zhou, G., Zhai, Y., Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population (2005) J Med Genet, 42, pp. 172-176 Sentani, K., Oue, N., Sakamoto, N., Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach (2008) Mod Pathol, 21, pp. 464-475 Zhang, B., Nie, X., Xiao, B., Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray (2003) Genes Chromosomes Cancer, 38, pp. 80-90 Chu, H.W., Thaikoottathil, J., Rino, J.G., Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation (2007) J Immunol, 179, pp. 3995-4002 Leclair, E.E., Four BPI (bactericidal/permeability-increasing protein)-like genes expressed in the mouse nasal, oral, airway and digestive epithelia (2003) Biochem Soc Trans, 31, pp. 801-805 Fabian, T.K., Hermann, P., Beck, A., Fejerdy, P., Fabian, G., Salivary defense proteins: Their network and role in innate and acquired oral immunity (2012) Int J Mol Sci, 13, pp. 4295-4320 Citrin, D.E., Hitchcock, Y.J., Chung, E.J., Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies (2012) Radiat Oncol, 7, p. 64 Tiwari, M., Science behind human saliva (2011) J Nat Sci Biol Med, 2, pp. 53-58 Trotti, A., Bellm, L.A., Epstein, J.B., Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review (2003) Radiother Oncol, 66, pp. 253-262 Sharma, A., Rath, G.K., Chaudhary, S.P., Thakar, A., Mohanti, B.K., Bahadur, S., Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study (2012) Eur J Cancer, 48, pp. 875-881 Jellema, A.P., Slotman, B.J., Doornaert, P., Leemans, C.R., Langendijk, J.A., Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer (2007) Int J Radiat Oncol Biol Phys, 69, pp. 751-760 Hopcraft, M.S., Tan, C., Xerostomia: An update for clinicians (2010) Aust Dent J, 55, pp. 238-244. , quiz 353 Lal, P., Bajpai, R., Khurana, R., Changes in salivary flow rates in head and neck cancer after chemoradiotherapy (2010) J Cancer Res Ther, 6, pp. 458-462 Karbach, J., Walter, C., Al-Nawas, B., Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation (2012) Clin Oral Invest, 16, pp. 1305-1312 Tiwana, M.S., Mahajan, M.K., Uppal, B., Whole saliva physico-biochemical changes and quality of life in head and neck cancer patients following conventional radiation therapy: A prospective longitudinal study (2011) Ind J Cancer, 48, pp. 289-295 Almstahl, A., Wikstrom, M., Electrolytes in stimulated whole saliva in individuals with hyposalivation of different origins (2003) Arch Oral Biol, 48, pp. 337-344 Sonis, S.T., Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity (1998) Oral Oncol, 34, pp. 39-43 Sonis, S.T., Mucositis: The impact, biology and therapeutic opportunities of oral mucositis (2009) Oral Oncol, 45, pp. 1015-1020 Gaetti-Jardim, E.J., Ciesielski, F.I., De Sousa, F.R., Nwaokorie, F., Schweitzer, C.M., Avila-Campos, M.J., Occurrence of yeasts, pseudomonads and enteric bacteria in the oral cavity of patients undergoing head and neck radiotherapy (2011) Braz J Microbiol, 42, pp. 1047-1055 Wijers, O.B., Levendag, P.C., Harms, E.R., Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: A placebo-controlled double-blind randomized study (2001) Int J Radiat Oncol Biol Phys, 50, pp. 343-352 Stokman, M.A., Spijkervet, F.K., Burlage, F.R., Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: A double-blind randomised clinical trial (2003) Br J Cancer, 88, pp. 1012-1016 El-Sayed, S., Nabid, A., Shelley, W., Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: A double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system (2002) J Clin Oncol, 20, pp. 3956-3963 Seshadri, S., Lin, D.C., Rosati, M., Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis (2012) Allergy, 67, pp. 920-928 Soysa, N.S., Samaranayake, L.P., Ellepola, A.N., Cytotoxic drugs, radiotherapy and oral candidiasis (2004) Oral Oncol, 40, pp. 971-978 Dijkema, T., Terhaard, C.H., Roesink, J.M., MUC5 B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: A pilot study (2012) Radiat Oncol, 7, p. 91 Mitas, M., Hoover, L., Silvestri, G., Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected] (2003) J Mol Diagnostics, 5, pp. 237-242 Lemaire, F., Millon, R., Young, J., Differential expression profiling of head and neck squamous cell carcinoma (HNSCC) (2003) Br J Cancer, 89, pp. 1940-1949 Ghafouri, B., Stahlbom, B., Tagesson, C., Lindahl, M., Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting (2002) Proteomics, 2, pp. 112-120 Naidu, M.U., Ramana, G.V., Rani, P.U., Mohan, I.K., Suman, A., Roy, P., Chemotherapy-induced and/or radiation therapy-induced oral mucositis - Complicating the treatment of cancer (2004) Neoplasia, 6, pp. 423-431 Sonis, S.T., Lindquist, L., Van Vugt, A., Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3 (1994) Cancer Res, 54, pp. 1135-1138 Helmerhorst, E.J., Oppenheim, F.G., Saliva: A dynamic proteome (2007) J Dent Res, 86, pp. 680-693 Bingle, C.D., Leclair, E.E., Havard, S., Bingle, L., Gillingham, P., Craven, C.J., Phylogenetic and evolutionary analysis of the PLUNC gene family (2004) Protein Sci, 13, pp. 422-430 Wheeler, T.T., Haigh, B.J., McCracken, J.Y., Wilkins, R.J., Morris, C.A., Grigor, M.R., The BSP30 salivary proteins from cattle, LUNX/PLUNC and von Ebner's minor salivary gland protein are members of the PSP/LBP superfamily of proteins (2002) Biochim Biophys Acta, 1579, pp. 92-100 Wheeler, T.T., Hood, K.A., Maqbool, N.J., McEwan, J.C., Bingle, C.D., Zhao, S., Expansion of the Bactericidal/Permeability Increasing-like (BPI-like) protein locus in cattle (2007) BMC Genomics, 8, p. 75 Robinson, C.P., Bounous, D.I., Alford, C.E., PSP expression in murine lacrimal glands and function as a bacteria binding protein in exocrine secretions (1997) Am J Physiol, 272, pp. 863-G871 Geetha, C., Venkatesh, S.G., Dunn, B.H., Gorr, S.U., Expression and anti-bacterial activity of human parotid secretory protein (PSP) (2003) Biochem Soc Trans, 31, pp. 815-818 Gorr, S.U., Sotsky, J.B., Shelar, A.P., Demuth, D.R., Design of bacteria-agglutinating peptides derived from parotid secretory protein, a member of the bactericidal/permeability increasing-like protein family (2008) Peptides, 29, pp. 2118-2127 Haigh, B., Hood, K., Broadhurst, M., The bovine salivary proteins BSP30 a and BSP30 b are independently expressed BPI-like proteins with anti-Pseudomonas activity (2008) Mol Immunol, 45, pp. 1944-1951 Khovidhunkit, W., Hachem, J.P., Medzihradszky, K.F., Parotid secretory protein is an HDL-associated protein with anticandidal activity (2005) Am J Physiol Regulat Integrat Comparat Physiol, 288, pp. 1306-R1315 Geetha, C., Venkatesh, S.G., Bingle, L., Bingle, C.D., Gorr, S.U., Design and validation of anti-inflammatory peptides from human parotid secretory protein (2005) J Dent Res, 84, pp. 149-153 Epstein, J.B., Chin, E.A., Jacobson, J.J., Rishiraj, B., Le, N., The relationships among fluoride, cariogenic oral flora, and salivary flow rate during radiation therapy (1998) Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 86, pp. 286-292 Epstein, J.B., Van Der Meij, E.H., Lunn, R., Stevenson-Moore, P., Effects of compliance with fluoride gel application on caries and caries risk in patients after radiation therapy for head and neck cancer (1996) Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 82, pp. 268-275 Tsou, Y.A., Peng, M.T., Wu, Y.F., Decreased PLUNC expression in nasal polyps is associated with multibacterial colonization in chronic rhinosinusitis patients (2014) Eur Arch Otorhinolaryngol, 271, pp. 299-304